U.S. Professional Services Stock News

It's been a good week for Sylvamo Corporation ( NYSE:SLVM ) shareholders, because the company has just released its...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Willis Lease Finance Corporation ( NASDAQ:WLFC ) will increase its dividend from last year's comparable payment on the...

Evergy, Inc.'s ( NASDAQ:EVRG ) dividend will be increasing from last year's payment of the same period to $0.695 on...

Gray Media, Inc.'s ( NYSE:GTN ) investors are due to receive a payment of $0.08 per share on 31st of December. Based on...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

The board of Granite Ridge Resources, Inc. ( NYSE:GRNT ) has announced that it will pay a dividend of $0.11 per share...

Inspire Medical Systems, Inc. ( NYSE:INSP ) recently posted some strong earnings, and the market responded positively...

The board of Snap-on Incorporated ( NYSE:SNA ) has announced that the dividend on 10th of December will be increased to...

Universal Logistics Holdings, Inc.'s ( NASDAQ:ULH ) investors are due to receive a payment of $0.105 per share on 2nd...

Unitil Corporation's ( NYSE:UTL ) robust recent earnings didn't do much to move the stock. We think this is due to...

Vitesse Energy, Inc.'s ( NYSE:VTS ) recent weak earnings report didn't cause a big stock movement. However, we believe...

Atkore (NYSE:ATKR) has had a great run on the share market with its stock up by a significant 16% over the last three...

Information Services Group, Inc. ( NASDAQ:III ) just released a solid earnings report, and the stock displayed some...

Let's talk about the popular Core & Main, Inc. ( NYSE:CNM ). The company's shares saw significant share price movement...

Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are...

Key Insights Given the large stake in the stock by institutions, Eastman Kodak's stock price might be vulnerable to...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Even if it's not a huge purchase, we think it was good to see that Teddy Price, the Independent Chairman of Red River...

Key Insights Kestrel Group's significant individual investors ownership suggests that the key decisions are influenced...

Key Insights Significant insider control over Lifezone Metals implies vested interests in company growth A total of 4...

Conduent recently reported third-quarter 2025 results, noting a year-over-year revenue decline to US$767 million and shifting from net income last year to a net loss of US$46 million, alongside a lowered full-year revenue forecast. Despite this financial setback, Conduent highlighted operational improvements, new AI-powered product offerings, and board changes as part of its ongoing business transformation efforts. We'll examine how the reduced 2025 revenue guidance and profitability...

Eledon Pharmaceuticals (ELDN) is in the spotlight after presenting Phase 2 clinical trial results for its lead drug, tegoprubart, aimed at preventing rejection in kidney transplant patients. The data, while mixed on headline endpoints, has intensified market and medical sector curiosity about the company’s pipeline. See our latest analysis for Eledon Pharmaceuticals. Eledon’s share price took a dramatic hit this week, dropping nearly 50% in a single day after the Phase 2 trial update. This...